多发性硬化症。通用型那他珠单抗——更廉价多发性硬化症药物的一步？
Multiple sclerosis. Generic glatiramer acetate--a step toward cheaper MS drugs?
机构信息
Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark.
出版信息
Nat Rev Neurol. 2016 Jan;12(1):5-6. doi: 10.1038/nrneurol.2015.224. Epub 2015 Dec 4.
PMID:26635211
Abstract
A randomized, double-blind, phase III trial of generic glatiramer acetate has shown equivalent efficacy and safety compared with the approved formulation, Copaxone. The impact of approval of generic glatiramer acetate, however, will mainly depend on the pricing of the drug.
摘要
一项随机、双盲、III 期临床试验表明，通用型那他珠单抗与已获批的 Copaxone 制剂具有等效的疗效和安全性。然而，通用型那他珠单抗获得批准的影响主要取决于该药物的定价。
Zotero 插件